Analysis of repeat stereotactic radiosurgery for progressive primary and metastatic CNS tumors

Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):527-32. doi: 10.1016/s0360-3016(02)02784-0.

Abstract

Purpose: To identify and evaluate the pretreatment and patient factors that would predict for complications after repeat radiosurgery.

Methods and materials: The data from 26 patients who underwent re-irradiation with Gamma Knife surgery after a previous procedure in the same or subjacent location were available for evaluation. The range of follow-up was 1-45 months (mean 10). The mean minimal and maximal initial dose and volume for all 26 patients was 16.2 Gy (range 12-22), 31.0 Gy (range 22.2-40.0), and 12.4 cm(3) (range 1.20-70.84), respectively. The mean marginal and maximal repeated radiosurgery dose and volume for all 26 patients was 14.9 Gy (range 12-22.5), 29.7 Gy (range 18.0-45.0) and 12.8 cm(3) (range 1.10-39.20), respectively.

Results: Tumor control was significantly better statistically (p = 0.0129) for benign tumors (6 of 6, 100% actuarial rate at 4 years) compared with malignant tumors (7 of 20, 35% actuarial rate at 3 years, 3 of 4 metastatic tumors and 2 of 10 primary malignant gliomas). The retreatment volume for radiosurgery correlated significantly with the probability of neurologic decline (any cause) (p = 0.0181).

Conclusion: Repeat radiosurgery can be performed for recurrent tumors with minimal central nervous system toxicity, especially for benign tumors, with reasonable tumor control.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Brain Neoplasms / secondary
  • Brain Neoplasms / surgery*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / surgery*
  • Proportional Hazards Models
  • Radiosurgery / adverse effects*
  • Regression Analysis
  • Reoperation
  • Retrospective Studies